Sale!

TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TNFRSF13B gene, also known as TACI, plays a crucial role in the immune system, particularly in the regulation and function of B cells, which are essential for producing antibodies. Mutations in the TNFRSF13B gene can lead to immunodeficiency common variable type 2 (CVID2), a condition characterized by a significant reduction in the levels of immunoglobulins. This reduction makes individuals more susceptible to infections, autoimmune diseases, and potentially an increased risk of certain cancers.

The genetic test for identifying mutations in the TNFRSF13B gene is a critical tool for diagnosing CVID2. Conducted at DNA Labs UAE, this test involves analyzing the patient’s DNA to detect any genetic alterations associated with the condition. The process provides vital information that can help in understanding the patient’s symptoms, predicting the disease course, and tailoring the management plan to improve the quality of life.

The cost of the TNFRSF13B Gene Immunodeficiency Common Variable Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the expenses related to the sophisticated laboratory techniques and expertise required to accurately identify mutations in the TNFRSF13B gene. Given the complexity of CVID2 and the significance of genetic factors in its management, this test represents a valuable resource for patients and healthcare providers alike, offering insights that can lead to more effective and personalized care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test

At DNA Labs UAE, we offer the TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test for individuals who suspect they may have common variable immunodeficiency type 2 (CVID2). This test can help diagnose CVID2 and provide valuable information for genetic counseling and treatment decisions.

Test Components and Price

  • Test Name: TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test
  • Price: 4400.0 AED

Sample Condition and Report Delivery

  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks

Method and Test Type

  • Method: NGS Technology (Next-Generation Sequencing)
  • Test Type: Osteology Dermatology Immunology Disorders

Doctor and Test Department

  • Doctor: Dermatologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with TNFRSF13B Gene Immunodeficiency common variable type 2 NGS Genetic DNA Test gene TNFRSF13B.

Test Details

The TNFRSF13B gene is associated with a type of immunodeficiency called common variable immunodeficiency type 2 (CVID2). CVID2 is a primary immunodeficiency disorder characterized by low levels of antibodies and recurrent infections.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. In the context of CVID2, NGS genetic testing can be used to identify mutations or variations in the TNFRSF13B gene that may be causing the immunodeficiency.

By identifying specific genetic variants in the TNFRSF13B gene, NGS genetic testing can help diagnose CVID2 and provide valuable information for genetic counseling and treatment decisions. It can also help identify other family members who may be at risk of developing the condition.

It is important to note that NGS genetic testing is just one tool used in the diagnosis and management of CVID2. Other clinical and laboratory tests may also be necessary to confirm the diagnosis and guide treatment.

Test Name TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TNFRSF13B Gene Immunodeficiency common variable type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TNFRSF13B Gene Immunodeficiency common variable type 2 NGS Genetic DNA Test gene TNFRSF13B
Test Details

The TNFRSF13B gene is associated with a type of immunodeficiency called common variable immunodeficiency type 2 (CVID2). CVID2 is a primary immunodeficiency disorder characterized by low levels of antibodies and recurrent infections.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. In the context of CVID2, NGS genetic testing can be used to identify mutations or variations in the TNFRSF13B gene that may be causing the immunodeficiency.

By identifying specific genetic variants in the TNFRSF13B gene, NGS genetic testing can help diagnose CVID2 and provide valuable information for genetic counseling and treatment decisions. It can also help identify other family members who may be at risk of developing the condition.

It is important to note that NGS genetic testing is just one tool used in the diagnosis and management of CVID2. Other clinical and laboratory tests may also be necessary to confirm the diagnosis and guide treatment.